Trials / Completed
CompletedNCT01161992
Genomics of Primary Sclerosing Cholangitis (PSC)
P.R.O.G.R.E.S.S.: PSC Resource Of Genetic Risk, Environment and Synergy Studies.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 5 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
Primary Sclerosing Cholangitis (PSC) is a progressive liver disorder of unknown cause. Current evidence suggests that genes, the genetic material we inherit from our parents, in combination with environmental factors, likely play an important role in the development of PSC. This study is being done to investigate whether genes make people more likely to develop PSC. Discovery of these genes will help us to better understand how PSC developes and subsequently, to apply new approaches for its prevention, diagnosis and treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | Genetic Analysis | Perform Genome Wide Association Studies. |
Timeline
- Start date
- 2002-03-01
- Primary completion
- 2025-07-01
- Completion
- 2025-07-31
- First posted
- 2010-07-14
- Last updated
- 2025-08-07
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01161992. Inclusion in this directory is not an endorsement.